Inicio › Melanoma › Minnesota › Minneapolis
Ensayos clínicos de Melanoma en Minneapolis, MN
12 estudios para Melanoma buscan participantes en centros de Minneapolis y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ReclutandoFase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutandoFase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · A 5 mi de distancia
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
ReclutandoFase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
ReclutandoFase 3
- University of Minnesota, Minneapolis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ReclutandoFase 1/2
- Minnesota Oncology and Hematology PA, Minneapolis
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
ReclutandoFase 2
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- y 1 más
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
ReclutandoFase 3
- University of Minnesota Medical Center, Minneapolis
Más información sobre Melanoma en MedlinePlus
Ensayos de Melanoma en otras ciudades
- Houston, TX61 estudios
- New York City, NY41 estudios
- Nashville, TN34 estudios
- Los Angeles, CA34 estudios
- Pittsburgh, PA31 estudios
- Boston, MA25 estudios
- St. Louis, MO23 estudios
- Durham, NC22 estudios
- Philadelphia, PA22 estudios
- Tampa, FL21 estudios
- Columbus, OH21 estudios
- Dallas, TX21 estudios
Otros estudios en Minneapolis
- Cáncer de pulmón de células no pequeñas29 estudios
- Cáncer de seno23 estudios
- Cáncer de ovario23 estudios
- Cáncer de próstata22 estudios
- Fallo cardíaco22 estudios
- Cáncer (todos los tipos)21 estudios
- Cáncer de endometrio20 estudios
- Cáncer del colon y del recto20 estudios
- Cáncer de pulmón20 estudios
- Leucemia mielógena aguda19 estudios
- Enfermedad de Parkinson17 estudios
- Enfermedad de las arterias coronarias15 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.